As on 04-Dec-2023 16:10 EST
$58.61
$58.69
$60.87
$58.69
216,188
$55.96 - 68.54
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Prestige Consumer Healthcare (PBH)
| -3.27 | 1.66 | 3.73 | -5.23 | 19.60 | 9.70 | 5.86 |
S&P BSE CDG&S*
| 33.25 | 8.96 | 9.57 | 27.66 | 21.51 | 15.38 | -- |
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.90 | -6.30 | 5.30 | 2.98 | 5.53 |
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
---|---|---|---|---|---|---|---|
Prestige Consumer Healthcare (PBH)
| 3.22 | 73.93 | -13.90 | 31.15 | -29.45 | -14.76 | 1.20 |
S&P Small-Cap 600
| -17.42 | 25.27 | 9.57 | 20.86 | -9.70 | 11.73 | 24.74 |
S&P BSE CDG&S
| -1.31 | 29.72 | 20.33 | -1.65 | -15.77 | 54.37 | 4.89 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
The total asset value of Prestige Consumer Healthcare Inc. (PBH) stood at $ 3,354 Mln as on 31-Mar-23
The share price of Prestige Consumer Healthcare Inc. (PBH) is $60.55 (NYSE) as of 04-Dec-2023 16:10 EST. Prestige Consumer Healthcare Inc. (PBH) has given a return of 19.6% in the last 3 years.
Prestige Consumer Healthcare Inc. (PBH) has a market capitalisation of $ 2,984 Mln as on 19-May-2023. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Prestige Consumer Healthcare Inc. (PBH) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Prestige Consumer Healthcare Inc. (PBH) and enter the required number of quantities and click on buy to purchase the shares of Prestige Consumer Healthcare Inc. (PBH).
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
The CEO & director of Mr. Ronald M. Lombardi. is Prestige Consumer Healthcare Inc. (PBH), and CFO & Sr. VP is Ms. Christine Sacco.
The promoters of Prestige Consumer Healthcare Inc. (PBH) have pledged 0% of the total equity as on Dec-22.
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
155
|
|
24
|
|
12
|
|
2,399
|
Prestige Consumer Healthcare Inc. (PBH) | Ratios |
---|---|
Return on equity(%)
|
-5.44
|
Return on capital employed(%)
|
-2.79
|
Debt-to-equity ratio
|
0.94
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Prestige Consumer Healthcare Inc. (PBH) was $-82 Mln.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two... segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. Read more
Sign up and get access to:
Unlimited access to advice from India's top experts
The most comprehensive analysis of funds and stocks in India
A holistic portfolio manager to help track all your investments easily
And much more, like guides, tools, webinars, videos and eBooks.